Tadayasu Togawa Selected Research

globotriaosyl lysosphingolipid

9/2021	Does administration of hydroxychloroquine/amiodarone accelerate accumulation of globotriaosylceramide and globotriaosylsphingosine in Fabry mice?
7/2015	Clinical and biochemical investigation of male patients exhibiting membranous cytoplasmic bodies in biopsied kidney tissues; a pitfall in diagnosis of Fabry disease.
1/2015	Nano-LC-MS/MS for Quantification of Lyso-Gb3 and Its Analogues Reveals a Useful Biomarker for Fabry Disease.
1/2014	Plasma mutant α-galactosidase A protein and globotriaosylsphingosine level in Fabry disease.
11/2012	Mutant α-galactosidase A with M296I does not cause elevation of the plasma globotriaosylsphingosine level.
9/2010	Tissue and plasma globotriaosylsphingosine could be a biomarker for assessing enzyme replacement therapy for Fabry disease.
7/2010	Plasma globotriaosylsphingosine as a biomarker of Fabry disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tadayasu Togawa Research Topics

Disease

24	Fabry Disease (Fabry's Disease) 01/2022 - 11/2009
5	Inborn Genetic Diseases (Disease, Hereditary) 01/2014 - 07/2010
3	Lysosomal Storage Diseases (Lysosomal Storage Disease) 09/2021 - 01/2016
3	Sandhoff Disease (Sandhoff's Disease) 01/2017 - 01/2011
2	Neoplasms (Cancer) 08/2007 - 07/2004
1	Chronic Renal Insufficiency 12/2021
1	Azoospermia 01/2020
1	Proteinuria 12/2019
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 12/2019
1	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2019
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2017
1	Gliosis 01/2017
1	GM2 Gangliosidoses (GM2 Gangliosidosis) 01/2016
1	Wilms Tumor (Wilm's Tumor) 05/2015
1	Chronic Kidney Failure (Chronic Renal Failure) 09/2012
1	Heart Diseases (Heart Disease) 04/2012
1	Tay-Sachs Disease 01/2011
1	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 08/2010
1	Hypersensitivity (Allergy) 11/2009
1	GM1 Gangliosidosis (Gangliosidosis GM1) 09/2009
1	Mucopolysaccharidosis IV (Morquio Syndrome) 09/2009
1	Aspartylglucosaminuria 12/2008
1	Mucopolysaccharidosis I (Hurler Syndrome) 09/2008
1	Glycogen Storage Disease Type II (Pompe's Disease) 05/2008

Drug/Important Bio-Agent (IBA)

12	GalactosidasesIBA 12/2021 - 04/2012
11	EnzymesIBA 01/2021 - 05/2008
9	globotriaosylceramide (globotriosylceramide)IBA 12/2021 - 11/2009
7	globotriaosyl lysosphingolipidIBA 09/2021 - 07/2010
6	Biomarkers (Surrogate Marker)IBA 08/2018 - 07/2010
5	alpha-Galactosidase (Beano)IBA 01/2022 - 07/2010
5	GlycosphingolipidsIBA 01/2017 - 02/2012
5	Proteins (Proteins, Gene)FDA Link 01/2014 - 12/2008
3	GlycolipidsIBA 12/2021 - 09/2010
2	Pharmaceutical PreparationsIBA 09/2021 - 07/2004
2	Mannose (D-Mannose)IBA 12/2020 - 01/2016
2	agalsidase beta FDA Link 12/2020 - 01/2015
2	agalsidase alfaIBA 12/2020 - 02/2012
2	Protein Isoforms (Isoforms)IBA 01/2017 - 01/2015
2	Hexosaminidases (Hexosaminidase)IBA 01/2017 - 01/2013
2	Hexosaminidase A (Hex A)IBA 01/2016 - 01/2011
2	AntibodiesIBA 05/2015 - 01/2015
2	NucleotidesIBA 09/2012 - 04/2012
1	Phospholipids (Phosphatides)FDA LinkGeneric 09/2021
1	CationsIBA 12/2020
1	CollagenIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Protamines (Protamine Sulfate)FDA Link 01/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2019
1	SteroidsIBA 12/2019
1	AutoantibodiesIBA 01/2017
1	G(M2) Ganglioside (Ganglioside GM2)IBA 01/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2017
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2017
1	Peptide Hydrolases (Proteases)FDA Link 01/2016
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2016
1	Hexosaminidase BIBA 01/2016
1	podocalyxinIBA 05/2015
1	VimentinIBA 05/2015
1	Glycoproteins (Glycoprotein)IBA 02/2012
1	Polysaccharides (Glycans)IBA 02/2012
1	GangliosidesIBA 01/2011
1	lysoganglioside G(M2)IBA 01/2011
1	palmitoyl-protein thioesteraseIBA 08/2010
1	alpha-N-Acetylgalactosaminidase (N-Acetyl-alpha-D-Galactosaminidase)IBA 11/2009
1	beta-Galactosidase (Lactaid)IBA 09/2009
1	Aspartylglucosylaminase (Aspartylglucosaminidase)IBA 12/2008
1	Iduronidase (alpha-L-Iduronidase)IBA 09/2008
1	alpha-Glucosidases (Acid Maltase)IBA 05/2008
1	Imino SugarsIBA 05/2008
1	AcidsIBA 05/2008
1	Cisplatin (Platino)FDA LinkGeneric 08/2007
1	MetallothioneinIBA 08/2007
1	Irinotecan (Camptosar)FDA LinkGeneric 07/2004
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 07/2004
1	CamptothecinIBA 07/2004
1	trioctyl phosphine oxide (TOPO)IBA 07/2004
1	Antineoplastic Agents (Antineoplastics)IBA 07/2004
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 07/2004

Therapy/Procedure

10	Enzyme Replacement Therapy 12/2020 - 11/2009
3	Therapeutics 01/2020 - 05/2008
2	Cell Transplantation 01/2021 - 01/2020
1	Immunotherapy 12/2019
1	Renal Dialysis (Hemodialysis) 09/2012
1	Drug Therapy (Chemotherapy) 07/2004